Abstract
A multicentre European study ofPseudomonas aeruginosa serotype O12 isolates with a common antibiotic resistance pattern was conducted. Resistance to β-lactams and aminoglycosides was observed in 24 of the 25 isolates, as often reported in Europe, and all 25 isolates were significantly more susceptible to fosfomycin than 189 isolates of other serotypes (72% vs. 13.2%). The mutational frequency of serotype O12 was similar to that of other serotypes and thus could not explain the susceptibility to fosfomycin. As a number of epidemiological studies using various methods, especially ribotyping withEcoRI, have shown that most strains are similar, it has been suggested that a single strain of this serotype is widespread. However, in this study ribotyping withEcoRI andPvull distinguished seven clones among 24 ticarcillin resistant serotype O12 isolates, although one ribotype predominated (67%). Thus the hypothesis of spread of one clone across Europe cannot explain the common resistance phenotype observed in different clones of serotype O12. Resistance of beta-lactams and aminoglycosides might be explained by greater receptiveness for transposable resistance mechanisms, and susceptibility to fosfomycin by increased permeability of the outer membrane.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jarvis WR, Martone WJ: Predominant pathogens in hospital infections. Journal of Antimicrobial Chemotherapy 1992, 29, Supplement A: 19–24.
Bodey GP, Bolivar R, Fainstein V, Jadeja L: Infections caused byPseudomonas aeruginosa. Reviews of Infectious Diseases 1983, 5: 278–313.
Véron M, Descamps R Daoulas F, Loulergue J, Weber M, Mallet MN, Lagrange R, Dabemat H, Lemeland JF, Morel C, Philippon A, Didion J, Vincent P: Étude multicentrique de la sensibilité dePseudomonas aeruginosa à six bêta-lactamines. Médecine et Maladies Infectieuses 1987, 6/7: 401–411.
Legakis NJ, Aliferopoulou M, Papavassilou J, Papapetropoulou M: Serotypes ofPseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility. Journal of Clinical Microbiology 1982, 16: 458–463.
Giamanco A, Di Stefano R, Arista S, Sinatra A, Chiarini A: Infections caused byPseudomonas aeruginosa: relatively frequent isolation of serogroup O12 from clinical specimens. European Journal of Epidemiology 1985, 1: 104–109.
Allemeersch D, Beumer J, Devleeschouwer M, De Maeyer S, Dony J, Godard C, Osterrieth P, Pithsy A, Van Der Auwera P, Van Poppel H, Verschraegen G, Wegge M: Marked increase ofPseudomonas aeruginosa serotype O12 in Belgium since 1982. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 265–269.
Patzer J, Dzierzanowska D: The incidence of serotype O12 and multiresistance amongstPseudomonas aeruginosa isolates. Journal of Antimicrobial Chemotherapy 1994, 34: 165–170.
Kahan FJS, Cassidy PJ, Kropp H: The mechanism of action of fosfomycin (phosphonomycin). Annals of New York Academy of Sciences 1974, 235: 364–386.
Courtieu AL, Drugeon H, Billaudel S: Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Chemotherapy 1977, 23, Supplement 1: 25–36.
Watine J, Bourrel C, Dubourdieu B, Gineston JL, Bories R, Durand M, Marre A, Formosa F, Brunel MR, Palliez J: Susceptibility of multiresistant serotype O12Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics. Pathologie Biologie 1994, 42: 293–295.
Pitt TL, Livermore DM, Pitcher D, Vatopoulos AC, Legakis NJ: Multiresistant serotype O12Pseudomonas aeruginosa: evidence for a common strain in Europe. Epidemiology and Infection 1989, 103: 565–576.
Wildemauwe C, Beumer J, De Meuter F, Devleeschouwer M, Dony J, Godard C, Pithsy A, Vanhoof R:Pseudomonas aeruginosa O12: résistance aux antibiotiques. Lysotypes et pyocinotypes de souches hospitalières. Médecine et Maladies Infectieuses 1989, 6/7: 345–350.
Barthélémy M, Guionie M, Labia R: Beta-lactamases: determinations of their isoelectric points. Antimicrobial Agents and Chemotherapy 1978, 13: 695–698.
Livermore DM, Pitt TL, Jones CS, Crees-Morris JA, Williams RJ: PSE-4 beta-lactamase: a serotype specific enzyme inPseudomonas aeruginosa. Journal of Medical Microbiology 1985, 19: 45–53.
Brenner DJ, McWhorter AC, Leete-Knudson JK, Steigerwalt AG:Escherichia vulneris: a new species ofEnterobacteriaceae associated with human wounds. Journal of Clinical Microbiology 1982, 15: 1133–1140.
Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 1975, 98: 503–517.
Grimont F, Chevrier D, Grimont PAD, Lefevre M, Guesdon JL: Acetylaminofluorene-labelled ribosomal RNA for use in molecular epidemiology and taxonomy. Research in Microbiology 1989, 140: 447–454.
Philippon A: Beta-lactamases ofPseudomonas aeruginosa. In: Livermore D (ed): Beta-lactamases: current perspectives. Theracom, The Hague, 1988, 63–81.
Grüner E, Kropec A, Huebner J, Altwegg M, Dashner F: Ribotyping ofPseudomonas aeruginosa strains isolated from surgical intensive care patients. Journal of Infectious Diseases 1993, 167: 1216–1220.
Pitt TL, Livermore DM, Miller G, Vatopoulos AC, Legakis NJ: Resistance of multiresistant serotype O12Pseudomonas aeruginosa isolated in Europe. Journal of Antimicrobial Chemotherapy 1990, 26: 319–328.
Michel-Briand Y, Alkhalaf-Haddad B, Bonnin M:Pseudomonas aeruginosa et antibiotiques. Bulletin de l'Institut Pasteur 1989, 87: 125–170.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Talarmin, A., Dubrous, P., Gérome, P. et al. Study ofPseudomonas aeruginosa serotype O12 isolates with a common antibiotic susceptibility pattern. Eur. J. Clin. Microbiol. Infect. Dis. 15, 459–464 (1996). https://doi.org/10.1007/BF01691312
Issue Date:
DOI: https://doi.org/10.1007/BF01691312